Status:

COMPLETED

Memory Training Intervention for Breast Cancer Survivors

Lead Sponsor:

Indiana University

Conditions:

Breast Cancer

Eligibility:

FEMALE

40+ years

Phase:

NA

Brief Summary

This is a randomized controlled trial to evaluate the ACTIVE memory training intervention and ACTIVE speed of processing training to waitlist, no-contact control conditions. Specific aims and hypothes...

Detailed Description

Memory deficits are a prevalent, bothersome, and potentially debilitating symptom for millions of breast cancer survivors (BCS). Evidence-based treatment is difficult because there has been little int...

Eligibility Criteria

Inclusion

  • female gender (breast cancer is rare in men);
  • self-reported memory impairment and desire for treatment (to focus on BCS in greatest need);
  • first diagnosis of non-metastatic breast cancer (to control for multiple treatments or brain metastases in women with recurrent or metastatic disease);
  • ≥ 1 year post-treatment including surgery, radiation, and/or chemotherapy (reduce confounding factors related to acute effects of treatment);32
  • age ≥ 40 years (our prior studies indicate approximately 75% of BCS meet this criterion and reduce sample variability);
  • post-menopausal (majority are post-menopausal at diagnosis and reduce sample variability); and
  • able to read, write, understand, and speak English (to ensure informed consent).

Exclusion

  • Women will be excluded if they have other co-morbidities or deficits that would sufficiently impair performance or inhibit cognitive training including:
  • substantial cognitive decline (score \< 24 on the Mini Mental State Exam (MMSE);33
  • history of stroke, encephalitis, traumatic brain injury, brain surgery, dementia, Alzheimer disease, or Parkinson disease;
  • cranial radiation therapy or intrathecal therapy;
  • current active major depression or substance abuse or history of bipolar disorder, psychosis, schizophrenia, or learning disability;
  • history of or current other cancer except for basal cell skin cancer; or
  • receiving other cognitive training (to avoid exposure to other training).

Key Trial Info

Start Date :

September 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2012

Estimated Enrollment :

88 Patients enrolled

Trial Details

Trial ID

NCT01497015

Start Date

September 1 2008

End Date

December 1 2012

Last Update

February 23 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Indiana University

Indianapolis, Indiana, United States, 46202